UNIVERSITY OF UTAH

UNIVERSITY OF UTAH logo
🇺🇸United States
Ownership
Private
Established
1850-02-28
Employees
10K
Market Cap
-
Website
http://www.utah.edu
Clinical Trials
Related News

Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram

Phase 2
Completed
Conditions
Major Depressive Disorder
Interventions
Drug: Creatine Monohydrate
First Posted Date
2009-02-25
Last Posted Date
2017-05-12
Lead Sponsor
University of Utah
Target Recruit Count
13
Registration Number
NCT00851006
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids

Phase 2
Withdrawn
Conditions
Macular Edema
Uveitis
Interventions
Drug: ranibizumab
Drug: triamcinolone
First Posted Date
2009-02-19
Last Posted Date
2014-12-11
Lead Sponsor
University of Utah
Registration Number
NCT00846625
Locations
🇺🇸

John Moran Eye Center, Salt Lake City, Utah, United States

Early Versus Standard Postpartum Insertion of the Etonogestrel Contraceptive Implant

First Posted Date
2009-02-19
Last Posted Date
2016-04-18
Lead Sponsor
University of Utah
Target Recruit Count
69
Registration Number
NCT00847587
Locations
🇺🇸

University of Utah Hospital, Salt Lake City, Utah, United States

Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma

Phase 1
Completed
Conditions
Cancer
Interventions
Drug: Fluorescein
First Posted Date
2009-02-19
Last Posted Date
2017-12-20
Lead Sponsor
University of Utah
Target Recruit Count
90
Registration Number
NCT00847522
Locations
🇺🇸

Huntsman Cancer Institute, Salt Lake City, Utah, United States

Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)

Completed
Conditions
Neurofibromatosis Type 1
First Posted Date
2009-02-13
Last Posted Date
2018-05-03
Lead Sponsor
University of Utah
Target Recruit Count
112
Registration Number
NCT00844129
Locations
🇺🇸

University Health Care, 50 North Medical Drive, Salt Lake City, Utah, United States

Oral Uridine for Treatment of Bipolar Depression in Adolescents

Phase 2
Completed
Conditions
Bipolar Disorder
Interventions
Drug: Uridine
First Posted Date
2009-02-11
Last Posted Date
2018-03-26
Lead Sponsor
University of Utah
Target Recruit Count
42
Registration Number
NCT00841269
Locations
🇺🇸

University of Utah School of Medicine, Salt Lake City, Utah, United States

Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure

Not Applicable
Terminated
Conditions
Patent Ductus Arteriosus
Prematurity
Interventions
Drug: Ibuprofen
First Posted Date
2009-02-02
Last Posted Date
2016-07-04
Lead Sponsor
University of Utah
Target Recruit Count
15
Registration Number
NCT00833365
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

Neuroendocrine Mechanisms of Growth and Body Composition in Preterm and Term Infants

Completed
Conditions
Premature Birth
First Posted Date
2009-02-02
Last Posted Date
2017-12-26
Lead Sponsor
University of Utah
Target Recruit Count
72
Registration Number
NCT00833222
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

Electronic Pharmacotherapy Risk Management

First Posted Date
2009-01-26
Last Posted Date
2010-03-23
Lead Sponsor
University of Utah
Target Recruit Count
174000
Registration Number
NCT00828490
Locations
🇺🇸

Multi-clinic site, Salt Lake City, Utah, United States

Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma

Phase 2
Terminated
Conditions
Cancer
Interventions
Drug: SOM230B
First Posted Date
2008-12-23
Last Posted Date
2014-06-11
Lead Sponsor
University of Utah
Target Recruit Count
2
Registration Number
NCT00813592
Locations
🇺🇸

Huntsman Cancer Institute, Salt Lake City, Utah, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy